Document:

Exhibit 4.2

 

NEITHER THIS SECURITY NOR THE SECURITIES
FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION
OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES
ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES
ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH
EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

 

Form of Underwriter’s Warrant

 

THE REGISTERED HOLDER
OF THIS PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE WARRANT EXCEPT
AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR
HYPOTHECATE THIS PURCHASE WARRANT FOR A PERIOD OF ONE HUNDRED EIGHTY (180) DAYS FOLLOWING THE LATER OF THE EFFECTIVE DATE (AS DEFINED
BELOW) OR THE COMMENCEMENT OF SALES OF THE OFFERING TO WHICH THIS PURCHASE WARRANT RELATES TO ANYONE OTHER THAN (I) LAIDLAW
& COMPANY (UK) lTD. OR AN UNDERWRITER OR A SELECTED DEALER IN CONNECTION WITH THE OFFERING, OR (II) A BONA FIDE OFFICER
OR PARTNER OF LAIDLAW & COMPANY (UK) lTD. OR OF ANY SUCH UNDERWRITER OR SELECTED
DEALER.

 

THIS PURCHASE WARRANT
IS NOT EXERCISABLE PRIOR TO [________________] [DATE THAT IS 180 DAYS FROM THE EFFECTIVE DATE OF THE OFFERING]. VOID AFTER
5:00 P.M., EASTERN TIME, [___________________] [DATE THAT IS FIVE YEARS FROM THE EFFECTIVE DATE OF THE OFFERING].

 

COMMON STOCK PURCHASE WARRANT

 

For the Purchase of [_____]1Shares
of Common Stock

of

AMESITE INC.

 

1. Purchase Warrant. THIS
CERTIFIES THAT, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, ______________
(“Holder”), as registered owner of this Purchase Warrant, is entitled, at any time or from time to time from
[________________] [DATE THAT IS ONE HUNDRED EIGHTY (180) DAYS FROM THE EFFECTIVE DATE OF THE OFFERING] (the “Commencement
Date”), and at or before 5:00 p.m., Eastern time, [____________] [DATE THAT IS FIVE YEARS FROM THE EFFECTIVE DATE
OF THE OFFERING] (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in
whole or in part, up to [____] (the “Shares”) of common stock, par value $0.0001 per share (the “Common
Stock”), of Amesite Inc., a Delaware corporation (the “Company”), subject to adjustment as provided
in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized or required by law or executive
order to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with
the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate
this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] per Share [equal to 120% of the price of
the shares sold in the Offering]; provided, however, that upon the occurrence of any of the events specified
in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares
to be received upon such exercise, shall be adjusted as therein specified. This Purchase Warrant is being issued in connection
with a public offering of shares of Common Stock pursuant to the Company’s registration statement on Form S-1 (File No.:
333-248001) (the “Offering”). The term “Exercise Price” shall mean the initial exercise price
or the adjusted exercise price, depending on the context. As used herein, “Effective Date” means the date on
which the Shares being sold in the Offering first become legally eligible for distribution to the public as determined in accordance
with FINRA Conduct Rule 5110(a)(12).

  

 

1
NTD: To be 5% of the aggregate number of shares of common stock sold in the offering, including over-allotment shares.

 

    -1-

     

    

 

2. Exercise.

 

2.1 Exercise Form.
In order to exercise this Purchase Warrant, the exercise form attached hereto must be duly executed and completed and delivered
to the Company, together with this Purchase Warrant and payment of the Exercise Price for the Shares being purchased payable in
cash by wire transfer of immediately available funds to an account designated by the Company or by certified check or official
bank check. If the subscription rights represented hereby shall not be exercised at or before 5:00 p.m., Eastern time, on the Expiration
Date, this Purchase Warrant shall become and be void without further force or effect, and all rights represented hereby shall cease
and expire.

 

2.2 Cashless Exercise.
If at any time after the Commencement Date there is no effective registration statement registering, or no current prospectus available
for, the resale of the Shares by the Holder, in lieu of exercising this Purchase Warrant by payment of cash or check payable to
the order of the Company pursuant to Section 2.1 above, Holder may elect to receive the number of Shares equal to the value of
this Purchase Warrant (or the portion thereof being exercised), by surrender of this Purchase Warrant to the Company, together
with the exercise form attached hereto, in which event the Company will issue to Holder Shares in accordance with the following
formula:

 

	X	=	Y(A-B)	 
	A	 

 

	Where,	 	 	 
	 	X	=	The number of Shares to be issued to Holder;
	 	Y	=	The number of Shares for which the Purchase Warrant is being exercised;
	 	A	=	The fair market value of one Share; and
	 	B	=	The Exercise Price.

 

For purposes of this
Section 2.2, the fair market value of a Share is defined as follows:

 

	 	(i)	if the Common Stock is traded on a securities exchange, the value shall be deemed to be the closing price on such exchange on the trading day prior to the exercise form being submitted in connection with the exercise of the Purchase Warrant;

 

	 	(ii)	if the Common Stock is actively traded on an over-the-counter market, the value shall be deemed to be the closing bid on the trading day prior to the exercise form being submitted in connection with the exercise of the Purchase Warrant; or

 

	 	(iii)	if there is no active public market in the United States, the value shall be the fair market value thereof, as determined in good faith by the Company’s Board of Directors.

 

    -2-

     

    

 

3. Transfer.

 

The registered Holder of this Purchase
Warrant agrees by his, her or its acceptance hereof, that such Holder will not: (a) sell, transfer, assign, pledge or hypothecate
this Purchase Warrant for a period of one hundred eighty (180) days following the later of the Effective Date or the commencement
of Effective Date or the commencement of sales of the Offering in accordance with FINRA Rule 5110(f)(2)(G)(iv) (the later of such
dates, the “Transferability Date”) to anyone other than: (i) Laidlaw & Company (UK) Ltd. (“Laidlaw”)
or an underwriter or a selected dealer participating in the Offering, or (ii) a bona fide officer or partner of Laidlaw or of any
such underwriter or selected dealer, in each case in accordance with FINRA Conduct Rule 5110(g)(1), or (b) cause this Purchase
Warrant or the securities issuable hereunder to be the subject of any hedging, short sale, derivative, put or call transaction
that would result in the effective economic disposition of this Purchase Warrant or the securities hereunder, except as provided
for in FINRA Rule 5110(g)(2). On and after the Transferability Date, transfers to others may be made subject to compliance with
or exemptions from applicable securities laws. In order to make any permitted assignment, the Holder must deliver to the Company
the assignment form attached hereto duly executed and completed, together with the Purchase Warrant and payment of all transfer
taxes, if any, payable in connection therewith. The Company shall within five (5) Business Days transfer this Purchase Warrant
on the books of the Company and shall execute and deliver a new Purchase Warrant or Purchase Warrants of like tenor to the appropriate
assignee(s) expressly evidencing the right to purchase the aggregate number of Shares purchasable hereunder or such portion of
such number as shall be contemplated by any such assignment. The registered Holder of this Purchase Warrant agrees by his, her
or its acceptance hereof, that such Holder will not sell, transfer, assign, pledge or hypothecate this Purchase Warrant.

 

The
securities evidenced by this Purchase Warrant shall not be transferred unless and until: (a) the Company has received the opinion
of counsel for the Holder that the securities may be transferred pursuant to an exemption from registration under the Securities
Act and applicable state securities laws, the availability of which is established to the reasonable satisfaction of the Company
(the Company hereby agreeing that the opinion of Lowenstein Sandler LLP shall be deemed satisfactory evidence of the availability
of an exemption), or (b) a registration statement or a post-effective amendment to a registration statement relating to the offer
and sale of such securities has been filed by the Company and declared effective by the U.S. Securities and Exchange Commission
(the “Commission”) and compliance with applicable state securities law has been established.

 

4. Registration Rights.

 

4.1 Reserved.

 

4.2 “Piggy-Back”
Registration.

 

4.2.1 Grant of Right.
Unless a registration statement covering the exercise of this Purchase Warrant and the sale of the Shares by the Holder is in effect
and available, the Holder shall have the right, for a period of no more than seven (7) years from the Transferability Date, to
include all or any portion of the Shares underlying the Purchase Warrants (collectively, the “Registrable Securities”)
as part of any other registration of securities filed by the Company (other than in connection with a transaction contemplated
by Rule 145(a) promulgated under the Securities Act, or pursuant to Form S-8 or any equivalent form); provided, however,
that if, solely in connection with any primary underwritten public offering for the account of the Company, the managing underwriter(s)
thereof shall, in its reasonable discretion, impose a limitation on the number of shares of Common Stock which may be included
in the registration statement because, in such underwriter(s)’ judgment, marketing or other factors dictate such limitation
is necessary to facilitate public distribution, then the Company shall be obligated to include in such registration statement only
such limited portion of the Registrable Securities with respect to which the Holder requested inclusion hereunder as the underwriter
shall reasonably permit. Any exclusion of Registrable Securities shall be made pro rata among the Holders seeking to include Registrable
Securities in proportion to the number of Registrable Securities sought to be included by such Holders; provided, however,
that the Company shall not exclude any Registrable Securities unless the Company has first excluded all outstanding securities,
the holders of which are not entitled to inclusion of such securities in such registration statement or are not entitled to pro
rata inclusion with the Registrable Securities. Notwithstanding the foregoing, the Company shall not be required to register any
Registrable Securities pursuant to this Section that are subject of a then effective registration statement.

 

    -3-

     

    

 

4.2.2 Terms.
The Company shall bear all fees and expenses attendant to registering the Registrable Securities pursuant to Section 4.2.1 hereof,
but the Holders shall pay any and all underwriting commissions and the expenses of any legal counsel selected by the Holders to
represent them in connection with the sale of the Registrable Securities. In the event of such a proposed registration, the Company
shall furnish the then Holders of outstanding Registrable Securities with not less than fifteen (15) days written notice prior
to the proposed date of filing of such registration statement. Such notice to the Holders shall continue to be given for each registration
statement filed by the Company until such time as all of the Registrable Securities have been sold by the Holder. The holders of
the Registrable Securities shall exercise the “piggy-back” rights provided for herein by giving written notice within
five (5) days of the receipt of the Company’s notice of its intention to file a registration statement. Except as otherwise
provided in this Purchase Warrant, there shall be no limit on the number of times the Holder may request registration under this
Section 4.2.2; provided, however, that such registration rights shall terminate on the seventh (7th) anniversary
of the Transferability Date.

 

4.3 General Terms.

 

4.3.1 Indemnification.
The Company shall indemnify the Holder(s) of the Registrable Securities to be sold pursuant to any registration statement hereunder
and each person, if any, who controls such Holders within the meaning of Section 15 of the Securities Act or Section 20(a) of the
Securities Exchange Act of 1934, as amended (“Exchange Act”), against all loss, claim, damage, expense or liability
(including all reasonable attorneys’ fees and other expenses reasonably incurred in investigating, preparing or defending
against any claim whatsoever) to which any of them may become subject under the Securities Act, the Exchange Act or otherwise,
arising from such registration statement but only to the same extent and with the same effect as the provisions pursuant to which
the Company has agreed to indemnify the Underwriters (as defined in the Underwriting Agreement) contained in Section 7(a) of the
Underwriting Agreement between Laidlaw & Company (UK) Ltd., as the representative of the several Underwriters named on Schedule
I thereto, and the Company, dated as of [●], 2019 (the “Underwriting Agreement”). The Holder(s) of the
Registrable Securities to be sold pursuant to such registration statement, and their successors and assigns, shall severally, and
not jointly, indemnify the Company, against all loss, claim, damage, expense or liability (including all reasonable attorneys’
fees and other expenses reasonably incurred in investigating, preparing or defending against any claim whatsoever) to which they
may become subject under the Securities Act, the Exchange Act or otherwise, arising from information furnished by or on behalf
of such Holders, or their successors or assigns, in writing, for specific inclusion in such registration statement to the same
extent and with the same effect as the provisions contained in Section 7(b) of the Underwriting Agreement pursuant to which the
Underwriters have agreed to indemnify the Company.

 

4.3.2 Exercise
of Purchase Warrants. Nothing contained in this Purchase Warrant shall be construed as requiring the Holder(s) to exercise
their Purchase Warrants prior to or after the initial filing of any registration statement or the effectiveness thereof.

 

4.3.3 Documents
Delivered to Holders. The Company shall furnish to each Holder participating in any of the foregoing offerings and to each
underwriter of any such offering, if any, a signed counterpart, addressed to such Holder or underwriter, of: (i) if such registration
includes an underwritten public offering, an opinion of counsel to the Company, dated the date of the closing under any underwriting
agreement related thereto, and (ii) if such registration includes an underwritten public offering, a “cold comfort”
letter dated the effective date of such registration statement and a letter dated the date of the closing under the underwriting
agreement, signed by the independent registered public accounting firm which has issued a report on the Company’s financial
statements included in such registration statement, in each case covering substantially the same matters with respect to such registration
statement (and the prospectus included therein) and, in the case of such accountants’ letter, with respect to events subsequent
to the date of such financial statements, as are customarily covered in opinions of issuer’s counsel and in accountants’
letters delivered to underwriters in underwritten public offerings of securities. The Company shall also deliver promptly to each
Holder participating in the offering requesting the correspondence and memoranda described below and to the managing underwriter,
if any, copies of all correspondence between the Commission and the Company, its counsel or auditors and all memoranda relating
to discussions with the Commission or its staff with respect to the registration statement and permit each Holder and underwriter
to do such investigation, upon reasonable advance notice, with respect to information contained in or omitted from the registration
statement as it deems reasonably necessary to comply with applicable securities laws or rules of FINRA. Such investigation shall
include access to books, records and properties and opportunities to discuss the business of the Company with its officers and
independent auditors, all to such reasonable extent and at such reasonable times as any such Holder shall reasonably request in
connection with the underwritten offering.

 

    -4-

     

    

 

4.3.4 Underwriting
Agreement. The Company shall enter into an underwriting agreement with the managing underwriter(s), if any, selected by any
Holders whose Registrable Securities are being registered pursuant to this Section 4, which managing underwriter shall be reasonably
satisfactory to the Company. Such agreement shall be reasonably satisfactory in form and substance to the Company, each Holder
and such managing underwriters, and shall contain such representations, warranties and covenants by the Company and such other
terms as are customarily contained in agreements of that type used by the managing underwriter. The Holders shall be parties to
any underwriting agreement relating to an underwritten sale of their Registrable Securities and may, at their option, require that
any or all the representations, warranties and covenants of the Company to or for the benefit of such underwriters shall also be
made to and for the benefit of such Holders. Such Holders shall not be required to make any representations or warranties to or
agreements with the Company or the underwriters except as they may relate to such Holders, their Shares and their intended methods
of distribution.

 

4.3.5 Documents
to be Delivered by Holder(s). Each of the Holder(s) participating in any of the foregoing offerings shall furnish to the Company
a completed and executed questionnaire provided by the Company requesting information customarily sought of selling security holders.
The Holder further agrees that it shall not be entitled to be named in a registration statement
filed under this Section 4 or use the related prospectus for offers and resales of Registrable Securities at any time, unless such
Holder has returned to the Company a response to any requests for information as described in the previous sentence. If the Holder
returns a request for information after its deadline, the Company shall use its commercially reasonable efforts to take such actions
as are required to name such Holder as a selling security holder in the registration statement or any pre-effective or post-effective
amendment thereto and to include (to the extent not theretofore included) in the registration statement the Registrable Securities
identified in such late request for information. The Holder acknowledges and agrees that the information in any request for information
as described in this Section will be used by the Company in the preparation of the registration statement registering for resale
the Registrable Securities and hereby consents to the inclusion of such information in such registration statement.

 

4.3.6 Damages.
Should the registration or the effectiveness thereof required by Section 4.2 hereof be delayed by the Company or the Company otherwise
fails to comply with such provisions, the Holder(s) shall, in addition to any other legal or other relief available to the Holder(s),
be entitled to obtain specific performance or other equitable (including injunctive) relief against the threatened breach of such
provisions or the continuation of any such breach, without the necessity of proving actual damages and without the necessity of
posting bond or other security.

 

5. New Purchase Warrants to be
Issued.

 

5.1 Partial
Exercise. Subject to the restrictions in Section 3 hereof, this Purchase Warrant may be exercised in whole or in part. In the
event of the exercise hereof in part only, upon surrender of this Purchase Warrant for cancellation, the Company shall cause to
be delivered to the Holder without charge a new Purchase Warrant of like tenor to this Purchase Warrant in the name of the Holder
evidencing the right of the Holder to purchase the number of Shares purchasable hereunder as to which this Purchase Warrant has
not been exercised.

 

5.2 Lost
Certificate. Upon receipt by the Company of evidence satisfactory to it of the loss, theft, destruction or mutilation of this
Purchase Warrant and of reasonably satisfactory indemnification or the posting of a bond, the Company shall execute and deliver
a new Purchase Warrant of like tenor and date. Any such new Purchase Warrant executed and delivered as a result of such loss, theft,
mutilation or destruction shall constitute a substitute contractual obligation on the part of the Company.

 

6. Adjustments.

 

6.1 Adjustments
to Exercise Price and Number of Securities. The Exercise Price and the number of Shares underlying the Purchase Warrant shall
be subject to adjustment from time to time as hereinafter set forth:

 

6.1.1 Share Dividends;
Split Ups. If, after the date hereof, and subject to the provisions of Section 6.3 below, the number of outstanding Shares
is increased by a stock dividend payable in Shares or by a split up of Shares or other similar event, then, on the effective day
thereof, the number of Shares purchasable hereunder shall be increased in proportion to such increase in outstanding Shares, and
the Exercise Price shall be proportionately decreased.

 

    -5-

     

    

 

6.1.2 Aggregation
of Shares. If, after the date hereof, and subject to the provisions of Section 6.3 below, the number of outstanding Shares
is decreased by a consolidation, combination, reverse stock split or reclassification of Shares or other similar event, then, on
the effective date thereof, the number of Shares purchasable hereunder shall be decreased in proportion to such decrease in outstanding
Shares, and the Exercise Price shall be proportionately increased.

 

6.1.3 Replacement
of Securities upon Reorganization, etc. In case of any reclassification or reorganization of the outstanding Shares other than
a change covered by Section 6.1.1 or 6.1.2 hereof or that solely affects the par value of such Shares, or in the case of any merger
or consolidation of the Company with or into another corporation (other than a merger or consolidation in which the Company is
the continuing corporation and that does not result in any reclassification or reorganization of the outstanding Shares), or in
the case of any sale or conveyance to another corporation or entity of the property of the Company as an entirety or substantially
as an entirety in connection with which the Company is dissolved, the Holder of this Purchase Warrant shall have the right thereafter
(until the expiration of the right of exercise of this Purchase Warrant) to receive upon the exercise hereof, for the same aggregate
Exercise Price payable hereunder (as adjusted pursuant to this Section 6.1.3) immediately prior to such event, the kind and amount
of shares of stock or other securities or property (including cash) receivable upon such reclassification, reorganization, share
reconstruction or amalgamation, or consolidation, or upon a dissolution following any such sale or transfer, by a Holder of the
number of Shares of the Company obtainable upon exercise of this Purchase Warrant immediately prior to such event; and if any reclassification
also results in a change in Shares covered by Section 6.1.1 or 6.1.2, then such adjustment shall be made pursuant to Sections 6.1.1,
6.1.2 and this Section 6.1.3. The provisions of this Section 6.1.3 shall similarly apply to successive reclassifications, reorganizations,
share reconstructions or amalgamations, or consolidations, sales or other transfers.

 

6.1.4 Changes
in Form of Purchase Warrant. This form of Purchase Warrant need not be changed because of any change pursuant to this Section
6.1, and Purchase Warrants issued after such change may state the same Exercise Price and the same number of Shares as are stated
in the Purchase Warrants initially issued pursuant to this Agreement. The acceptance by any Holder of the issuance of new Purchase
Warrants reflecting a required or permissive change shall not be deemed to waive any rights to an adjustment occurring after the
Commencement Date or the computation thereof.

 

6.2 Substitute
Purchase Warrant. In case of any merger or consolidation of the Company with or into another corporation (other than a merger
or consolidation which does not result in any reclassification or change of the outstanding Shares), the corporation formed by
such merger or consolidation shall execute and deliver to the Holder a supplemental Purchase Warrant providing that the holder
of each Purchase Warrant then outstanding or to be outstanding shall have the right thereafter (until the stated expiration of
such Purchase Warrant) to receive, upon exercise of such Purchase Warrant, the kind and amount of shares of stock and other securities
and property receivable upon such merger or consolidation, by a holder of the number of Shares of the Company for which such Purchase
Warrant might have been exercised immediately prior to such merger or consolidation, sale or transfer. Such supplemental Purchase
Warrant shall provide for adjustments which shall be identical to the adjustments provided for in this Section 6. The above provision
of this Section shall similarly apply to successive mergers or consolidations.

 

6.3 Elimination
of Fractional Interests. The Company shall not be required to issue certificates representing fractions of Shares upon the
exercise of the Purchase Warrant, nor shall it be required to issue scrip it being the intent of the parties that all fractional
interests shall be eliminated by paying cash in lieu of any fractional interests.

 

7. Reservation and Listing.
The Company shall at all times reserve and keep available out of its authorized Shares, solely for the purpose of issuance upon
exercise of the Purchase Warrants, such number of Shares or other securities, properties or rights as shall be issuable upon the
exercise thereof. The Company covenants and agrees that, upon exercise of the Purchase Warrants and payment of the Exercise Price
therefor, in accordance with the terms hereby, all Shares and other securities issuable upon such exercise shall be duly and validly
issued, fully paid and non-assessable and not subject to preemptive rights of any shareholder. As long as the Purchase Warrants
shall be outstanding, the Company shall use its commercially reasonable efforts to cause all Shares issuable upon exercise of the
Purchase Warrants to be listed (subject to official notice of issuance) on all national securities exchanges (or, if applicable,
on the OTC Markets or any successor trading market) on which the Shares issued to the public in the Offering may then be listed
and/or quoted.

 

    -6-

     

    

 

8. Certain Notice Requirements.

 

8.1 Holder’s
Right to Receive Notice. Nothing herein shall be construed as conferring upon the Holders the right to vote or consent or to
receive notice as a shareholder for the election of directors or any other matter, or as having any rights whatsoever as a shareholder
of the Company. If, however, at any time prior to the expiration of the Purchase Warrants and their exercise, any of the events
described in Section 8.2 shall occur, then, in one or more of said events, the Company shall give written notice of such event
at least ten (10) days prior to the date fixed as a record date or the date of closing the transfer books for the determination
of the shareholders entitled to such dividend, distribution, conversion or exchange of securities or subscription rights, or entitled
to vote on such proposed dissolution, liquidation, winding up or sale. Such notice shall specify such record date or the date of
the closing of the transfer books, as the case may be. Notwithstanding the foregoing, the Company shall deliver to each Holder
a copy of each notice given to the other shareholders of the Company at the same time and in the same manner that such notice is
given to the shareholders.

 

8.2 Events
Requiring Notice. The Company shall be required to give the notice described in this Section 8 upon one or more of the following
events: (i) if the Company shall take a record of the holders of its Shares for the purpose of entitling them to receive a dividend
or distribution payable otherwise than in cash, or a cash dividend or distribution payable otherwise than out of retained earnings,
as indicated by the accounting treatment of such dividend or distribution on the books of the Company, (ii) the Company shall offer
to all the holders of its Shares any additional shares of capital stock of the Company or securities convertible into or exchangeable
for shares of capital stock of the Company, or any option, right or warrant to subscribe therefor, or (iii) a dissolution, liquidation
or winding up of the Company (other than in connection with a consolidation or share reconstruction or amalgamation) or a sale
of all or substantially all of its property, assets and business shall be proposed. Failure to give such notice shall not invalidate
any such action.

 

8.3 Notice
of Change in Exercise Price. The Company shall, promptly after an event requiring a change in the Exercise Price pursuant to
Section 6 hereof, send notice to the Holders of such event and change (“Price Notice”). The Price Notice shall
describe the event causing the change and the method of calculating same and shall be certified as being true and accurate by the
Company’s Principal Financial Officer.

 

8.4 Transmittal
of Notices. All notices, requests, consents and other communications under this Purchase Warrant shall be in writing and shall
be deemed to have been duly made when hand delivered, or mailed by express mail or private courier service: (i) if to the registered
Holder of the Purchase Warrant, to the address of such Holder as shown on the books of the Company, or (ii) if to the Company,
to following address or to such other address as the Company may designate by notice to the Holders:

 

If to the Holder:

 

Laidlaw & Company (UK) Ltd.

521 Fifth Avenue, 12th Floor

New York, NY 10175

Attention: Francis Ryan Smith

Fax No.: (212) 354-8783

 

If to the Company:

 

607 Shelby St. Ste. 700, PMB 214

Detroit, MI 48266

Attn: Chief Executive Officer

Fax No: (###) ###-####

 

    -7-

     

    

 

9. Miscellaneous.

 

9.1 Amendments.
The Company and Laidlaw may from time to time supplement or amend this Purchase Warrant without the approval of any of the Holders
in order to cure any ambiguity, to correct or supplement any provision contained herein that may be defective or inconsistent with
any other provisions herein, or to make any other provisions in regard to matters or questions arising hereunder that the Company
and Laidlaw may deem necessary or desirable and that the Company and Laidlaw deem shall not adversely affect the interest of the
Holders. All other modifications or amendments shall require the written consent of and be signed by the party against whom enforcement
of the modification or amendment is sought.

 

9.2 Headings.
The headings contained herein are for the sole purpose of convenience of reference, and shall not in any way limit or affect the
meaning or interpretation of any of the terms or provisions of this Purchase Warrant.

 

9.3. Entire
Agreement. This Purchase Warrant (together with the other agreements and documents being delivered pursuant to or in connection
with this Purchase Warrant) constitutes the entire agreement of the parties hereto with respect to the subject matter hereof, and
supersedes all prior agreements and understandings of the parties, oral and written, with respect to the subject matter hereof.

 

9.4 Binding
Effect. This Purchase Warrant shall inure solely to the benefit of and shall be binding upon, the Holder and the Company and
their respective successors, assigns and legal representatives, and no other person shall have or be construed to have any legal
or equitable right, remedy or claim under or in respect of or by virtue of this Purchase Warrant or any provisions herein contained.

 

9.5 Governing
Law; Submission to Jurisdiction; Trial by Jury. This Purchase Warrant shall be governed by and construed and enforced in accordance
with the laws of the State of New York, without giving effect to conflict of laws principles thereof. The Company hereby agrees
that any action, proceeding or claim against it arising out of, or relating in any way to this Purchase Warrant shall be brought
and enforced in the New York Supreme Court, County of New York, or in the United States District Court for the Southern District
of New York, and irrevocably submits to such jurisdiction, which jurisdiction shall be exclusive. The Company hereby waives any
objection to such exclusive jurisdiction and that such courts represent an inconvenient forum. The Company and the Holder agree
that the prevailing party(ies) in any such action shall be entitled to recover from the other party(ies) all of its reasonable
attorneys’ fees and expenses relating to such action or proceeding and/or incurred in connection with the preparation therefor.
The Company (on its behalf and, to the extent permitted by applicable law, on behalf of its stockholders and affiliates) and the
Holder hereby irrevocably waive, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal
proceeding arising out of or relating to this Agreement or the transactions contemplated hereby.

 

9.6 Waiver,
etc. The failure of the Company or the Holder to at any time enforce any of the provisions of this Purchase Warrant shall not
be deemed or construed to be a waiver of any such provision, nor to in any way affect the validity of this Purchase Warrant or
any provision hereof or the right of the Company or any Holder to thereafter enforce each and every provision of this Purchase
Warrant. No waiver of any breach, non-compliance or non-fulfillment of any of the provisions of this Purchase Warrant shall be
effective unless set forth in a written instrument executed by the party or parties against whom or which enforcement of such waiver
is sought; and no waiver of any such breach, non-compliance or non-fulfillment shall be construed or deemed to be a waiver of any
other or subsequent breach, non-compliance or non-fulfillment.

 

9.7 Execution
in Counterparts. This Purchase Warrant may be executed in one or more counterparts, and by the different parties hereto in
separate counterparts, each of which shall be deemed to be an original, but all of which taken together shall constitute one and
the same agreement, and shall become effective when one or more counterparts has been signed by each of the parties hereto and
delivered to each of the other parties hereto. Such counterparts may be delivered by facsimile transmission or other electronic
transmission.

 

9.8 Exchange
Agreement. As a condition of the Holder’s receipt and acceptance of this Purchase Warrant, Holder agrees that, at any
time prior to the complete exercise of this Purchase Warrant by Holder, if the Company and Laidlaw enter into an agreement (“Exchange
Agreement”) pursuant to which they agree that all outstanding Purchase Warrants will be exchanged for securities or cash
or a combination of both, then Holder shall agree to such exchange and become a party to the Exchange Agreement.

 

[Signature Page Follows]

 

    -8-

     

    

 

IN WITNESS WHEREOF, the Company has caused
this Purchase Warrant to be signed by its duly authorized officer as of the ____ day of ______________, 2020.

 

	AMESITE INC.	 
	 	 	 
	By:	 	 
	 	Name: Ann Marie Sastry	 
	 	Title: Chief Executive Officer	 

 

 

    -9-

     

    

 

[Form to be used to exercise Purchase
Warrant]

 

Date: __________, 20___

 

The undersigned
hereby elects irrevocably to exercise the Purchase Warrant for ______ shares of Common Stock (the “Shares”)
of Amesite Inc., a Delaware corporation (the “Company”), and hereby makes payment of $____ (at the rate of $____
per Share) in payment of the Exercise Price pursuant thereto. Please issue the Shares as to which this Purchase Warrant is exercised
in accordance with the instructions given below and, if applicable, a new Purchase Warrant representing the number of Shares for
which this Purchase Warrant has not been exercised.

 

or

 

The undersigned
hereby elects irrevocably to convert its right to purchase ___ Shares of the Company under the Purchase Warrant for ______ Shares,
as determined in accordance with the following formula:

 

	 	X	=	Y(A-B)	 
	A	 

 

	Where,	 	 	 
	 	X	=	The number of Shares to be issued to Holder;
	 	Y	=	The number of Shares for which the Purchase Warrant is being exercised;
	 	A	=	The fair market value of one Share which is equal to $_____; and
	 	B	=	The Exercise Price which is equal to $______ per share

 

The undersigned
agrees and acknowledges that the calculation set forth above is subject to confirmation by the Company and any disagreement with
respect to the calculation shall be resolved by the Company in its sole discretion.

 

Please issue
the Shares as to which this Purchase Warrant is exercised in accordance with the instructions given below and, if applicable, a
new Purchase Warrant representing the number of Shares for which this Purchase Warrant has not been converted.

 

	 	Signature 	 	 

 

 

INSTRUCTIONS FOR REGISTRATION OF SECURITIES

 

	Name:	 	 
	 	(Print in Block Letters)	 

 

	Address:	 	 
	 	 	 
	 	 	 

 

NOTICE: The signature to this form must
correspond with the name as written upon the face of the Purchase Warrant without alteration or enlargement or any change whatsoever,
and must be guaranteed by a bank, other than a savings bank, or by a trust company or by a firm having membership on a registered
national securities exchange.

  

    -10-

     

    

 

ASSIGNMENT FORM

 

(To assign the
foregoing Purchase Warrant, execute this form and supply required information. Do not use this form to purchase Shares.)

 

FOR VALUE RECEIVED,
the foregoing Purchase Warrant and all rights evidenced thereby are hereby assigned to

 

	Name:	 	 
	 	 	(Please Print)
	 	 	 
	Address:	 	 
	 	 	(Please Print)
	 	 	 
	Phone Number:	 	
	Email Address:	 	 
	 	 	 
	Dated: _______________ __, ______	 	 
	 	 	 
	Holder’s Signature: _____________________	 	 
	 	 	 
	Holder’s Address: _____________________	 	 

 

    -11-Exhibit 10.2

 

FORM
OF

REGISTRATION
RIGHTS AGREEMENT

 

This
Registration Rights Agreement (this “Agreement”) is made and entered into effective as of ___, 2019,
among Amesite Inc., a Delaware corporation (the “Company”), the persons who have purchased the Offering
Shares and have executed omnibus or counterpart signature page(s) hereto (each, a “Purchaser” and collectively,
the “Purchasers”), and the persons or entities identified on Schedule 1 hereto holding Placement
Agent Warrants (collectively, the “Brokers”). Capitalized terms used herein shall have the meanings
ascribed to them in Section 1 below or in the Subscription Agreement.

 

RECITALS:

 

WHEREAS,
the Company has offered and sold in compliance with Rule 506 of Regulation D promulgated under the Securities Act to accredited
investors in a private placement offering (the “Offering”) shares of the common stock of the Company,
par value $0.0001 per share, pursuant to that certain Subscription Agreement entered into by and between the Company and each
of the subscribers for the Offering Shares set forth on the signature pages affixed thereto (the “Subscription Agreement”);
and

 

WHEREAS,
the Company has agreed to enter into a registration rights agreement with each of the Purchasers in the Offering who purchased
the Offering Shares and with the Brokers, or their designees, who hold Placement Agent Warrants.

 

NOW,
THEREFORE, in consideration of the mutual promises, representations, warranties, covenants, and conditions set forth herein,
the parties mutually agree as follows:

 

1. Certain
Definitions. As used in this Agreement, the following terms shall have the following respective meanings:

 

“Approved
Market” means the OTC Markets Group, the Nasdaq Stock Market, the New York Stock Exchange or the NYSE American.

 

“Blackout
Period” means, with respect to a registration, a period during which the Company, in the good faith judgment
of its board of directors, determines (because of the existence of, or in anticipation of, any acquisition, financing
activity or other transaction involving the Company, or the unavailability for reasons beyond the Company’s control of
any required financial statements, disclosure of information which is in its best interest not to publicly disclose, or any
other event or condition of similar significance to the Company) that the registration and distribution of the Registrable
Securities to be covered by such registration statement, if any, or the filing of an amendment to such registration statement
in the circumstances described in Section 4(h), would be seriously detrimental to the Company and its stockholders, in each
case commencing on the day the Company notifies the Holders that they are required, because of the determination described
above, to suspend offers and sales of Registrable Securities and ending on the earlier of (1) the date upon which the
material non-public information resulting in the Blackout Period is disclosed to the public or, in the sole discretion of the
Company, ceases to be material and (2) such time as the Company notifies the selling Holders that sales pursuant to such
Registration Statement or a new or amended Registration Statement may resume; provided, however, that no
Blackout Period shall extend for a period of more than thirty (30) consecutive Trading Days and aggregate Blackout Periods
shall not exceed sixty (60) Trading Days in any twelve (12) month period.

 

     

     

    

 

“Business
Day” means any day of the year, other than a Saturday, Sunday, or other day on which banks in the State of New York
are required or authorized to close.

 

“Commission”
means the U.S. Securities and Exchange Commission or any other federal agency at the time administering the Securities Act.

 

“Common
Stock” means the common stock, par value $0.0001 per share, of the Company and any and all shares of capital stock
or other equity securities of: (i) the Company which are added to or exchanged or substituted for the Common Stock by reason of
the declaration of any stock dividend or stock split, the issuance of any distribution or the reclassification, readjustment,
recapitalization or other such modification of the capital structure of the Company; and (ii) any other corporation, now or hereafter
organized under the laws of any state or other governmental authority, with which the Company is merged, which results from any
consolidation or reorganization to which the Company is a party, or to which is sold all or substantially all of the shares or
assets of the Company, if immediately after such merger, consolidation, reorganization or sale, the Company or the stockholders
of the Company own equity securities having in the aggregate more than 50% of the total voting power of such other corporation.

 

“Effective
Date” means the date of the final closing of the Offering.

 

“Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission promulgated
thereunder.

 

“Family
Member” means (a) with respect to any individual, such individual’s spouse, any descendants (whether natural
or adopted), any trust all of the beneficial interests of which are owned by any of such individuals or by any of such individuals
together with any organization described in Section 501(c)(3) of the Internal Revenue Code of 1986, as amended, the estate of
any such individual, and any corporation, association, partnership or limited liability company all of the equity interests of
which are owned by those above described individuals, trusts or organizations and (b) with respect to any trust, the owners of
the beneficial interests of such trust.

 

“Holder”
means (i) each Purchaser or any of such Purchaser’s respective successors and Permitted Assignees who acquire rights in
accordance with this Agreement with respect to any Registrable Securities directly or indirectly from a Purchaser or from any
Permitted Assignee; and (ii) each Broker or any of such Broker’s respective successors and Permitted Assignees who acquire
rights in accordance with this Agreement with respect to any Registrable Securities directly or indirectly from an Broker or from
any Permitted Assignee.

 

“Majority
Holders” means, at any time, Holders of a majority of the Registrable Securities then outstanding.

 

    2

     

    

 

“Permitted Assignee” means (a) with respect to a partnership, its partners or former partners in accordance
with their partnership interests, (b) with respect to a corporation, its stockholders in accordance with their interest in the
corporation, (c) with respect to a limited liability company, its members or former members in accordance with their interest
in the limited liability company, (d) with respect to an individual party, any Family Member of such party, (e) an entity or trust
that is controlled by, controls, or is under common control with a transferor, or (f) a party to this Agreement.

 

“Placement
Agent Warrants” shall have the meaning set forth in the Subscription Agreement.

 

“Offering
Shares” means the shares of Common Stock issued to the Purchasers pursuant to the Subscription Agreement and any
shares of Common Stock issued or issuable with respect to such shares upon any stock split, dividend or other distribution, recapitalization
or similar event with respect to the foregoing.

 

The
terms “register,” “registered,” and “registration”
refer to a registration effected by preparing and filing a registration statement in compliance with the Securities Act, and the
declaration or ordering of the effectiveness of such registration statement.

 

“Registrable
Securities” means (a) the Offering Shares, and (b) the shares of Common Stock issuable upon exercise of the Placement
Agent Warrants; but, in each case, excluding any otherwise Registrable Securities that (i) have been sold or otherwise transferred
other than to a Permitted Assignee, or (ii) may be sold at the time under the Securities Act without restriction, including manner
of sale, current information requirements or volume limitations either pursuant to Rule 144 of the Securities Act or otherwise
during any ninety (90) day period.

 

“Registration
Default Period” means the period during which any Registration Event occurs and is continuing.

 

“Registration Effectiveness Date” means the date that is one hundred and fifty (150) calendar days after the
Effective Date.

 

“Registration
Event” means the occurrence of any of the following events:

 

(a) the
Company fails to file with the Commission the Registration Statement on or before the Registration Filing Date;

 

(b) the
Registration Statement is not declared effective by the Commission on or before the Registration Effectiveness Date;

 

(c) after
the SEC Effective Date, the Registration Statement ceases for any reason to remain continuously effective or the Holders are
otherwise not permitted to utilize the prospectus therein to resell the Registrable Securities for a period of more than
fifteen (15) consecutive Trading Days, except for Blackout Periods permitted herein and except for suspension of the use of
the Registration Statement in connection with its post-effective amendment in connection with the filing of the
Company’s Annual Report on Form 10-K for the time reasonably required to respond to any comments from the staff
of the Commission (the “Staff”) on the Form 10-K, and as excused pursuant to Section 3(a); or

 

    3

     

    

 

(d) following
the listing or inclusion for quotation on an Approved Market, the Registrable Securities, if issued and outstanding, are not listed
or included for quotation on an Approved Market, or trading of the Common Stock is suspended or halted on the Approved Market,
which at the time constitutes the principal markets for the Common Stock, for more than three (3) full, consecutive Trading Days;
provided, however, a Registration Event shall not be deemed to occur if all or substantially all trading in equity securities
(including the Common Stock) is suspended or halted on the Approved Market for any length of time.

 

“Registration
Filing Date” means the date that is sixty (60) calendar days after the Effective Date.

 

“Registration
Statement” means the registration statement that the Company is required to file pursuant to Section 3(a) of this
Agreement to register the Registrable Securities.

 

“Rule
144” means Rule 144 promulgated by the Commission under the Securities Act, as such rule may be amended or supplemented
from time to time, or any similar successor rule that may be promulgated by the Commission.

 

“Rule
145” means Rule 145 promulgated by the Commission under the Securities Act, as such rule may be amended or supplemented
from time to time, or any similar successor rule that may be promulgated by the Commission.

 

“Rule
415” means Rule 415 promulgated by the Commission under the Securities Act, as such rule may be amended or supplemented
from time to time, or any similar successor rule that may be promulgated by the Commission.

 

“Securities
Act” means the Securities Act of 1933, as amended, or any similar federal statute promulgated in replacement thereof,
and the rules and regulations of the Commission thereunder, all as the same shall be in effect at the time.

 

“SEC
Effective Date” means the date the Registration Statement is declared effective by the Commission.

 

“Trading Day” means any day on which such national securities exchange, the OTC Markets Group or such other
securities market or quotation system, which at the time constitutes the principal securities market for the Common Stock, is
open for general trading of securities.

 

2. Term.
This Agreement shall terminate with respect to each Holder on the earlier of: (i) the date that is three (3) year(s) from the
SEC Effective Date and (ii) the date on which all Registrable Securities held by such Holder have been transferred other than
to a Permitted Assignee. Notwithstanding the foregoing, Section 3(b), Section 6, Section 8, Section 9 and Section 11
shall survive the termination of this Agreement.

 

    4

     

    

 

3. Registration.

 

(a) Registration
on Form S-1. The Company shall file with the Commission a Registration Statement on Form S-1, or any other form for
which the Company then qualifies or which counsel for the Company shall deem appropriate and which form shall be available
for the resale by the Holders of all of the Registrable Securities, and the Company shall (i) use its commercially reasonable
efforts to make the initial filing of the Registration Statement with the Commission no later than the Registration Filing
Date, (ii) use its commercially reasonable efforts to cause such Registration Statement to be declared effective no later
than the Registration Effectiveness Date and (iii) use its commercially reasonable efforts to keep such Registration
Statement effective for a period of three (3) year(s) after the SEC Effective Date or for such shorter period ending on the
date on which all Registrable Securities have been transferred other than to a Permitted Assignee (the
“Effectiveness Period”); provided, however, that the Company shall not be obligated
to effect any such registration, qualification or compliance pursuant to this Section, or keep such registration effective
pursuant to the terms hereunder, in any particular jurisdiction in which the Company would be required to qualify to do
business as a foreign corporation or as a dealer in securities under the securities laws of such jurisdiction or to execute a
general consent to service of process in effecting such registration, qualification or compliance, in each case where it has
not already done so; and provided further, the Company shall be entitled to suspend the effectiveness of the Registration
Statement at any time prior to the expiration of the Effectiveness Period during a Blackout Period. Notwithstanding the
foregoing, in the event that the Staff should limit the number of Registrable Securities that may be sold pursuant to
the Registration Statement, the Company may remove from the Registration Statement such number of Registrable Securities as
specified by the Commission on behalf of all of the holders of Registrable Securities first from the shares of Common Stock
issuable upon exercise of the Placement Agent Warrants, on a pro-rata basis among the holders thereof (and on an as-exercised
basis with respect to any Placement Agent Warrants not then exercised), second, from the other Registrable Securities, on a
pro rata basis among the holders thereof (such Registrable Securities, the “Reduction Securities”).
In such event, the Company shall give the Purchasers prompt notice of the number of Registrable Securities excluded
therefrom. The Company shall use its commercially reasonable efforts at the first opportunity that is permitted by the
Commission to register for resale the Reduction Securities (pro rata among the Holders of such Reduction Securities) using
one or more registration statements that it is then entitled to use. The Company shall use its commercially reasonable
efforts to cause each such registration statement to be declared effective under the Securities Act as soon as possible, and
shall use its commercially reasonable efforts to keep such registration statement continuously effective under the Securities
Act during the entire Effectiveness Period. Notwithstanding the foregoing, the Company shall be entitled to suspend the
effectiveness of such Registration Statement at any time prior to the expiration of the Effectiveness Period for the reasons
and time periods during a Blackout Period. No liquidated damages shall accrue or be payable to any Holder pursuant to Section
3(b) with respect to any Registrable Securities that are excluded by reason of the Staff limiting the number of Registrable
Securities that may be sold pursuant to a registration statement; provided that the Company continues to use commercially
reasonable efforts to register such Registrable Securities for resale by other available means. Notwithstanding anything
herein to the contrary, if the Commission limits the Company’s ability to file, or prohibits or delays the filing of a
new registration statement, the Company’s compliance with such limitation, prohibition or delay solely to the extent
of such limitation, prohibition or delay shall not be deemed a failure by the Company to use commercially reasonable efforts
as set forth above or elsewhere in this Agreement and shall not require the payment of any liquidated damages by the Company
under this Agreement.

 

    5

     

    

 

(b) Liquidated
Damages. If a Registration Event occurs, then the Company will make payments to each Holder of Registrable Securities, as
liquidated damages to such Holder by reason of the Registration Event, a cash sum calculated at a rate of twelve percent (12%)
per annum of the total of the following, to the extent applicable to such Holder: (i) if the Holder purchased Registrable Securities
pursuant to the Subscription Agreement, the aggregate purchase price paid by such Holder pursuant to the Subscription Agreement,
or (ii) if the Holder is a Placement Agent or a designee of a Placement Agent, the exercise price of Placement Agent Warrants,
but in each case of (i) and (ii), only with respect to such Holder’s Registrable Securities that are affected by such Registration
Event and only for the period during which such Registration Event continues to affect such Registrable Securities. Notwithstanding
the foregoing, the maximum amount of liquidated damages that may be paid by the Company pursuant to this Section 3(b) shall be
an amount equal to five percent (5%) of the applicable foregoing amounts described in clauses (i) and (ii) in the preceding sentence
with respect to such Holder’s Registrable Securities that are affected by all Registration Events in the aggregate. Each
payment of liquidated damages pursuant to this Section 3(b) shall be due and payable in arrears within five (5) days after the
end of each full 30-day period of the Registration Default Period until the termination of the Registration Default Period and
within five (5) days after such termination. The Registration Default Period shall terminate upon the earlier of such time as
the Registrable Securities that are affected by the Registration Event cease to be Registrable Securities or (i) the filing of
the Registration Statement in the case of clause (a) of the definition of Registration Event, (ii) the SEC Effective Date in the
case of clause (b) of the definition of Registration Event, (iii) the ability of the Holders to effect sales pursuant to the Registration
Statement in the case of clause (c) of the definition of Registration Event, and (iv) the listing or inclusion and/or trading
of the Common Stock on an Approved Market, as the case may be, in the case of clause (d) of the definition of Registration Event.
The amounts payable as liquidated damages pursuant to this Section 3(b) shall be payable in lawful money of the United States.
Notwithstanding the foregoing, the Company will not be liable for the payment of liquidated damages described in this Section
3(b) for any delay in registration of Registrable Securities that would otherwise be includable in the Registration Statement
pursuant to Rule 415, solely as a result of a comment received from the Staff requiring a limit on the number of Registrable Securities
included in such Registration Statement in order for such Registration Statement to be able to avail itself of Rule 415, or, with
respect to any Holder, if such Holder fails to provide to the Company information concerning the Holder and manner of distribution
of the Holder’s Registrable Securities that is required by SEC Rules to be disclosed in a registration statement utilized
in connection with the registration of the Registrable Securities. In the event of any such circumstance, the Company will use
its commercially reasonable efforts at the first opportunity that is permitted by the Commission to register for resale the Registrable
Securities that have been cut back from being registered pursuant to Rule 415 only with respect to that portion of the Holders’
Registrable Securities that are then Registrable Securities.

 

    6

     

    

 

(c) Other
Limitations. Notwithstanding the provisions of Section 3(b) above, if (i) the Commission does not declare the
Registration Statement effective on or before the Registration Effectiveness Date, or (ii) the Commission allows the
Registration Statement to be declared effective at any time before or after the Registration Effectiveness Date, subject to
the withdrawal of certain Registrable Securities from the Registration Statement, and the reason for (i) or (ii) is the
Commission’s determination that (x) the offering of any of the Registrable Securities constitutes a primary offering of
securities by the Company, (y) Rule 415 may not be relied upon for the registration of the resale of any or all of the
Registrable Securities, and/or (z) a Holder of any Registrable Securities must be named as an underwriter, the Holders
understand and agree that in the case of (ii) the Company may (notwithstanding anything to the contrary contained herein)
reduce, on a pro rata basis, in the manner provided above, the total number of Registrable Securities to be registered on
behalf of each such Holder, and in the case of (i) or (ii) the Holder shall not be entitled to liquidated damages with
respect to the Registrable Securities not registered for the reason set forth in (i) or so reduced on a pro rata basis as set
forth in (ii) above. The Company shall use its commercially reasonable efforts at the first opportunity that is permitted by
the Commission to register for resale the Reduction Securities (pro rata among the Holders of such Reduction Securities)
using one or more registration statements that it is then entitled to use. The Company shall use its commercially reasonable
efforts to cause each such registration statement to be declared effective under the Securities Act as soon as possible, and
shall use its commercially reasonable efforts to keep such registration statement continuously effective under the Securities
Act during the entire Effectiveness Period. No liquidated damages shall accrue or be payable to any Holder pursuant to this
Section 3(c) with respect to any Registrable Securities that are excluded by reason of the Staff limiting the number of
Registrable Securities that may be sold pursuant to a registration statement; provided that the Company continues to use
commercially reasonable efforts to register such Registrable Securities for resale by other available means.
Notwithstanding anything herein to the contrary, if the Commission limits the Company’s ability to file, or prohibits
or delays the filing of a new registration statement, the Company’s compliance with such limitation, prohibition or
delay solely to the extent of such limitation, prohibition or delay shall not be deemed a failure by the Company to use
commercially reasonable efforts as set forth above or elsewhere in this Agreement and shall not require the payment of any
liquidated damages by the Company under this Agreement.

 

(d) If
the Company receives a written notice from the Holders of at least 50% of the Registrable Securities then outstanding that
they desire to distribute the Registrable Securities held by them (or a portion thereof) by means of an underwritten offering
or a block trade, the Company shall use commercially reasonable efforts to promptly engage one or more underwriter(s) or
investment bank(s) to conduct such an offering of the Registrable Securities (a “Secondary
Offering”). The underwriter(s) or investment bank(s) will be selected by the Company and shall be reasonably
acceptable to the Holders of a majority of the Registrable Securities providing such notice. All Holders proposing to
distribute their securities through such Secondary Offering shall enter into an underwriting agreement or other agreement(s),
including any lock-up or market standoff agreements, in customary form with the underwriter(s) or investment bank(s) selected
for such Secondary Offering as may be mutually agreed upon among the Company, the underwriter(s) or investment bank(s) and
the selling Holders. In connection with a Secondary Offering, the Company shall enter into and perform its obligations under
an underwriting agreement or other agreement(s), in usual and customary form as may be mutually agreed upon among the
Company, the underwriter(s) or investment bank(s) and the selling Holders. Notwithstanding any other provision of this
Section 3(d), if the underwriter(s) or investment bank(s) advise(s) such Holders that marketing factors require a limitation
on the number of shares to be offered in the Secondary Offering, then the number of shares, including the Registrable
Securities, that may be included in such Secondary Offering shall be allocated among such Holders of Registrable
Securities, and any other holders of shares, as follows: (i) first to such Holders of Registrable Securities in proportion
(as nearly as practicable) to the number of Registrable Securities owned by each such Holder or in such other proportion as
shall mutually be agreed to by all such selling Holders; and (ii) second to all other holders of securities included in the
Secondary Offering.

 

    7

     

    

 

4. Registration
Procedures. The Company will keep each Holder reasonably advised as to the filing and effectiveness of the Registration Statement.
At its expense with respect to the Registration Statement, the Company will:

 

(a) prepare
and file with the Commission with respect to the Registrable Securities, a Registration Statement in accordance with Section 3(a)
hereof, and use its commercially reasonable efforts to cause such Registration Statement to become effective and to remain effective
for the Effectiveness Period;

 

(b) not
name any Holder in the Registration Statement as an underwriter without that Holder’s prior written consent;

 

(c) if
the Registration Statement is subject to review by the Commission, promptly respond to all comments and diligently pursue resolution
of any comments to the satisfaction of the Commission;

 

(d) prepare
and file with the Commission such amendments and supplements to such Registration Statement as may be necessary to keep such Registration
Statement effective during the Effectiveness Period;

 

(e) not
less than four (4) Trading Days prior to filing a Registration Statement or any related prospectus or any amendment or supplement
thereto, the Company shall furnish to the Holders that hold at least 5% of Registrable Securities (appropriately adjusted for
any stock split, dividend, combination or other recapitalization) copies of or a link to all such documents proposed to be filed
(other than those incorporated by reference) and duly consider any comments received by the Holders;

 

(f) furnish,
without charge, to each Holder of Registrable Securities covered by such Registration Statement (i) a reasonable number of copies
of such Registration Statement (including any exhibits thereto other than exhibits incorporated by reference), each amendment
and supplement thereto as such Holder may reasonably request, (ii) such number of copies of the prospectus included in such Registration
Statement (including each preliminary prospectus and any other prospectus filed under Rule 424 of the Securities Act) as such
Holders may reasonably request, in conformity with the requirements of the Securities Act, and (iii) such other documents as such
Holder may reasonably require to consummate the disposition of the Registrable Securities owned by such Holder, but only during
the Effectiveness Period; provided that the Company shall have no obligation to furnish any document pursuant to this clause that
is available on the EDGAR system;

 

    8

     

    

 

(g) use
its commercially reasonable efforts to register or qualify such registration under such other applicable securities laws of
such jurisdictions within the United States as any Holder of Registrable Securities covered by such Registration Statement
reasonably requests and as may be necessary for the marketability of the Registrable Securities (such request to be made by
the time the applicable Registration Statement is deemed effective by the Commission) and do any and all other acts and
things necessary to enable such Holder to consummate the disposition in such jurisdictions of the Registrable Securities
owned by such Holder; provided, that the Company shall not be required to (i) qualify generally to do business in any
jurisdiction where it would not otherwise be required to qualify but for this paragraph, (ii) subject itself to taxation in
any such jurisdiction, or (iii) consent to general service of process in any such jurisdiction where it has not already done
so;

 

(h) as
promptly as practicable after becoming aware of such event, notify each Holder of Registrable Securities, the disposition of which
requires delivery of a prospectus relating thereto under the Securities Act, of the happening of any event, which comes to the
Company’s attention, that will after the occurrence of such event cause the prospectus included in such Registration Statement,
if not amended or supplemented, to contain an untrue statement of a material fact or an omission to state a material fact required
to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made,
not misleading and the Company shall promptly thereafter prepare and furnish to such Holder a supplement or amendment to such
prospectus (or prepare and file appropriate reports under the Exchange Act) so that, as thereafter delivered to the purchasers
of such Registrable Securities, such prospectus shall not contain an untrue statement of a material fact or omit to state any
material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under
which they were made, not misleading, unless suspension of the use of such prospectus otherwise is authorized herein or in the
event of a Blackout Period, in which case no supplement or amendment need be furnished (or Exchange Act filing made) until the
termination of such suspension or Blackout Period; provided that any and all information provided to the Holder pursuant to such
notification shall remain confidential to each Holder until such information otherwise becomes public, unless disclosure by a
Holder is required by law;

 

(i) comply,
and continue to comply during the Effectiveness Period, in all material respects with the Securities Act and the Exchange Act
and with all applicable rules and regulations of the Commission with respect to the disposition of all securities covered by such
Registration Statement;

 

(j) as
promptly as practicable after becoming aware of such event, notify each Holder of Registrable Securities being offered or sold
pursuant to the Registration Statement of the issuance by the Commission or any other federal or state governmental authority
of any stop order or other suspension of effectiveness of the Registration Statement or the initiation of any proceedings for
that purpose;

 

(k) use
its commercially reasonable efforts to cause the shares of Common Stock to be quoted or listed on an Approved Market;

 

(l) provide
a transfer agent and registrar, which may be a single entity, for the shares of Common Stock at all times and cooperate with
the Holders to facilitate the timely preparation and delivery of the Registrable Securities to be delivered to a transferee
pursuant to the Registration Statement (whether electronically or in certificated form) which Registrable Securities shall be
free, to the extent permitted by the Subscription Agreement, of all restrictive legends, and to enable such Registrable
Securities to be in such denominations and registered in such names as any such Holders may request;

 

    9

     

    

 

(m) cooperate
with the Holders of Registrable Securities being offered pursuant to the Registration Statement to issue and deliver, or cause
its transfer agent to issue and deliver, certificates representing Registrable Securities to be offered pursuant to the Registration
Statement within a reasonable time after the delivery of certificates representing the Registrable Securities to the transfer
agent or the Company, as applicable, and enable such certificates to be in such denominations or amounts as the Holders may reasonably
request and registered in such names as the Holders may request;

 

(n) notify
the Holders, the Placement Agents and their counsel as promptly as reasonably possible and (if requested by any such Person) confirm
such notice in writing no later than one (1) Trading Day following the day: (i)(A) when a Prospectus or any prospectus supplement
or post-effective amendment to a Registration Statement is proposed to be filed; (B) when the Commission notifies the Company
whether there will be a “no review,” “review” or a “completion of a review” of such Registration
Statement and whenever the Commission comments in writing on such Registration Statement (in which case the Company shall provide
true and complete copies thereof and all written responses thereto to each of the Holders that pertain to the Holders as a selling
stockholder, but not information which the Company believes would constitute material and non-public information); and (C) with
respect to each Registration Statement or any post-effective amendment, when the same has been declared effective, provided, however,
that such notice under this clause (C) shall be delivered to each Holder; (ii) of any request by the Commission or any other federal
or state governmental authority for amendments or supplements to a Registration Statement or prospectus or for additional information
that pertains to the Holders as selling stockholders; (iii) of the receipt by the Company of any notification with respect to
the suspension of the qualification or exemption from qualification of any of the Registrable Securities for sale in any jurisdiction,
or the initiation or threatening of any proceeding for such purpose; (iv) of the occurrence of any event or passage of time that
makes the financial statements included in a Registration Statement ineligible for inclusion therein or any statement made in
a Registration Statement or Prospectus or any document incorporated or deemed to be incorporated therein by reference untrue in
any material respect or that requires any revisions to a Registration Statement, Prospectus or other documents so that, in the
case of a Registration Statement or the Prospectus, as the case may be, it will not contain any untrue statement of a material
fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in light of
the circumstances under which they were made, not misleading; or (v) of the occurrence or existence of any pending corporate development
with respect to the Company that the Company believes may be material and that, in the determination of the Company, makes it
not in the best interest of the Company to allow continued availability of a Registration Statement or Prospectus, provided,
however, in no event shall any such notice contain any information which would constitute material, non-public information
regarding the Company or any of its Subsidiaries;

 

    10

     

    

 

(o) during
the Effectiveness Period, refrain from bidding for or purchasing any Common Stock or any right to purchase Common Stock or
attempting to induce any person to purchase any such security or right if such bid, purchase or attempt would in any way
limit the right of the Holders to sell Registrable Securities by reason of the limitations set forth in Regulation M of the
Exchange Act;

 

(p) use
its commercially reasonable efforts to avoid the issuance of, or, if issued, obtain the withdrawal of (i) any order stopping or
suspending the effectiveness of a Registration Statement, or (ii) any suspension of the qualification (or exemption from qualification)
of any of the Registrable Securities for sale in any jurisdiction, at the earliest practicable moment;

 

(q) cooperate
with any broker-dealer through which a Holder proposes to resell its Registrable Securities in effecting a filing with the FINRA
Corporate Financing Department pursuant to FINRA Rule 5110, as requested by any such Holder, and the Company shall pay the filing
fee required by such filing within two (2) Trading Days of the request therefor; and

 

(r) take
all other commercially reasonable actions necessary to enable, expedite, or facilitate the Holders to dispose of the Registrable
Securities by means of the Registration Statement during the term of this Agreement.

 

5. Obligations
of the Holders.

 

(a) Each
Holder agrees that, upon receipt of any notice from the Company of the happening of any event of the kind described in Section
4(h) hereof or of the commencement of a Blackout Period, such Holder shall discontinue the disposition of Registrable Securities
included in the Registration Statement until such Holder’s receipt of the copies of the supplemented or amended prospectus
contemplated by Section 4(h) hereof or notice of the end of the Blackout Period.

 

(b) The
Holders of the Registrable Securities shall provide such information as may reasonably be requested by the Company in connection
with the preparation of any registration statement, including amendments and supplements thereto, in order to effect the registration
of any Registrable Securities under the Securities Act pursuant to Section 3(a) of this Agreement and in connection with the Company’s
obligation to comply with federal and applicable state securities laws, including a completed questionnaire in the form attached
to the Subscription Agreement as Annex A (a “Selling Securityholder Questionnaire”) or any update thereto
not later than three (3) Business Days following a request therefore from the Company.

 

(c) Each
Holder, by its acceptance of the Registrable Securities, agrees to cooperate with the Company as reasonably requested by the Company
in connection with the preparation and filing of any Registration Statement hereunder, unless such Holder has notified the Company
in writing of its election to exclude all of its Registrable Securities from such Registration Statement.

 

    11

     

    

 

6. Registration
Expenses. The Company shall pay all expenses in connection with any registration obligation provided herein, including,
without limitation, all registration, filing, stock exchange fees, printing expenses, any FINRA filing fees, all fees and
expenses of complying with applicable securities laws, and the fees and disbursements of counsel for the Company provided,
that, in any underwritten registration or other Secondary Offering, the Company shall have no obligation to pay any
underwriting discounts, selling commissions or transfer taxes attributable to the Registrable Securities being sold by the
Holders thereof, which underwriting discounts, selling commissions and transfer taxes shall be borne by such Holders. Except
as provided in this Section 6 and Section 8 of this Agreement, the Company shall not be responsible for the expenses of any
attorney or other advisor employed by a Holder or for any other fees, disbursements and expenses incurred by Holders not
specifically agreed to in this Agreement.

 

7. Assignment
of Rights. No Holder may assign its rights under this Agreement to any party without the prior written consent of the
Company; provided, however, that any Holder may assign its rights under this Agreement without such consent (a)
to a Permitted Assignee as long as (i) such transfer or assignment is effected in accordance with applicable securities laws;
(ii) such transferee or assignee agrees in writing to become bound by and subject to the terms of this Agreement; and
(iii) such Holder notifies the Company in writing of such transfer or assignment, stating the name and address of the
transferee or assignee and identifying the Registrable Securities with respect to which such rights are being transferred or
assigned; or (b) as otherwise permitted under the Subscription Agreement or the Placement Agent Warrants. The Company may not
assign this Agreement or any rights or obligations hereunder without the prior written consent of the other party hereto
(other than by merger or consolidation or to an entity which acquires the Company including by way of acquiring all or
substantially all of the Company’s assets).

 

8. Indemnification.

 

(a) The
Company shall, and hereby does, indemnify and hold harmless, to the fullest extent permitted by law, each Holder, any
Permitted Assignee thereof, and their respective directors, officers, partners, employees and agents and each other person,
if any, who controls or is under common control with such Holder within the meaning of Section 15 of the Securities Act
(collectively, the “Holder Indemnified Parties”), against any losses, claims, damages or
liabilities, joint or several, and expenses to which the Holder Indemnified Parties may become subject under the Securities
Act or otherwise, insofar as such losses, claims, damages, liabilities or expenses (or actions or proceedings, whether
commenced or threatened, in respect thereof) arise out of or are based upon any untrue statement or alleged untrue statement
of any material fact contained in any registration statement prepared and filed by the Company under which Registrable
Securities were registered under the Securities Act, any preliminary prospectus, final prospectus or summary prospectus
contained therein, or any amendment or supplement thereto, or any omission or alleged omission to state therein a material
fact required to be stated or necessary to make the statements therein in light of the circumstances in which they were made
not misleading, and the Company shall reimburse the Holder Indemnified Parties for any legal or any other expenses reasonably
incurred by them in connection with investigating, defending or settling any such loss, claim, damage, liability, action or
proceeding; provided, however, that the Company shall not be liable in any such case (i) to the extent, but
only to the extent, that any such loss, claim, damage, liability (or action or proceeding in respect thereof) or expense
arises solely out of or is solely based upon (x) an untrue statement in or omission from such registration statement, any
such preliminary prospectus, final prospectus, summary prospectus, amendment or supplement in reliance upon and in conformity
with written information included in the Selling Securityholder Questionnaire, attached hereto as Annex A, furnished by a
Holder or its representative (acting on such Holder’s behalf) to the Company expressly for use in the preparation
thereof or (y) the failure of a Holder to comply with the covenants and agreements contained in Section 5 hereof respecting
the sale of Registrable Securities; or (ii) if the person asserting any such loss, claim, damage, liability (or action or
proceeding in respect thereof) who purchased the Registrable Securities that are the subject thereof did not receive a copy
of an amended preliminary prospectus or the final prospectus (or the final prospectus as amended or supplemented) at or prior
to the written confirmation of the sale of such Registrable Securities to such person because of the failure of such Holder
to so provide such amended preliminary or final prospectus and the untrue statement or omission of a material fact made in
such preliminary prospectus was corrected in the amended preliminary or final prospectus (or the final prospectus as amended
or supplemented). Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf
of the Holder Indemnified Parties and shall survive the transfer of such shares by the Holder.

 

    12

     

    

 

(b) As
a condition to including Registrable Securities in any registration statement filed pursuant to this Agreement, each Holder agrees,
severally and not jointly, to be bound by the terms of this Section 8 and to indemnify and hold harmless, to the fullest extent
permitted by law, the Company, each of its directors, officers, partners, and each underwriter, if any, and each other person,
if any, who controls the Company within the meaning of Section 15 of the Securities Act, against any losses, claims, damages or
liabilities, joint or several, to which the Company or any such director or officer or controlling person may become subject under
the Securities Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions or proceedings, whether commenced
or threatened, in respect thereof) arise solely out of or are solely based upon any untrue statement of a material fact or any
omission of a material fact required to be stated in any registration statement, any preliminary prospectus, final prospectus,
summary prospectus, amendment or supplement thereto or necessary to make the statements therein not misleading, to the extent,
but only to the extent, that such untrue statement or omission is included or omitted in reliance upon and in conformity with
written information included in the Selling Securityholder Questionnaire, attached hereto as Annex A, furnished by the Holder
or its representative (acting on such Holder’s behalf) to the Company expressly for use in the preparation thereof, and
such Holder shall reimburse the Company, and its directors, officers, partners, and any such controlling persons for any legal
or other expenses reasonably incurred by them in connection with investigating, defending, or settling any such loss, claim, damage,
liability, action, or proceeding; provided, however, that indemnity obligation contained in this Section 8(b) shall
in no event exceed the amount of the net proceeds received by such Holder as a result of the sale of such Holder’s Registrable
Securities pursuant to such registration statement. Such indemnity shall remain in full force and effect, regardless of any investigation
made by or on behalf of the Company or any such director, officer or controlling person and shall survive the transfer by any
Holder of such shares.

 

    13

     

    

 

(c) Promptly
after receipt by an indemnified party of notice of the commencement of any action or proceeding involving a claim referred
to in this Section 8 (including any governmental action), such indemnified party shall, if a claim in respect thereof is to
be made against an indemnifying party, give written notice to the indemnifying party of the commencement of such action; provided,
that the failure of any indemnified party to give notice as provided herein shall not relieve the indemnifying party of its
obligations under this Section, except to the extent that the indemnifying party is actually prejudiced by such failure to
give notice in any material respect. In case any such action is brought against an indemnified party, unless in the
reasonable judgment of counsel to such indemnified party a conflict of interest between such indemnified party and
indemnifying parties may exist or the indemnified party may have defenses not available to the indemnifying party in respect
of such claim, the indemnifying party shall be entitled to participate in and to assume the defense thereof, with counsel
reasonably satisfactory to such indemnified party and, after notice from the indemnifying party to such indemnified party of
its election so to assume the defense thereof, the indemnifying party shall not be liable to such indemnified party for any
legal or other expenses subsequently incurred by the latter in connection with the defense thereof, unless in such
indemnified party’s reasonable judgment a conflict of interest between such indemnified and indemnifying parties arises
in respect of such claim after the assumption of the defenses thereof or the indemnifying party fails to defend such claim in
a diligent manner, other than reasonable costs of investigation. Neither an indemnified party nor an indemnifying party shall
be liable for any settlement of any action or proceeding effected without its consent. No indemnifying party shall, without
the consent of the indemnified party, consent to entry of any judgment or enter into any settlement, which does not include
as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of a release from all
liability in respect of such claim or litigation. Notwithstanding anything to the contrary set forth herein, and
without limiting any of the rights set forth above, in any event any party shall have the right to retain, at its own
expense, counsel with respect to the defense of a claim. Each indemnified party shall furnish such information regarding
itself or the claim in question as an indemnifying party may reasonably request in writing and as shall be reasonably
required in connection with defense of such claim and litigation resulting therefrom.

 

(d) If
an indemnifying party does not or is not permitted to assume the defense of an action pursuant to Section 8(c) or in the case
of the expense reimbursement obligation set forth in Sections 8(a) and 8(b), the indemnification required by Sections 8(a) and
8(b) shall be made by periodic payments of the amount thereof during the course of the investigation or defense, as and when bills
are received or expenses, losses, damages, or liabilities are incurred.

 

(e) If
the indemnification provided for in Section 8(a) or 8(b) is held by a court of competent jurisdiction to be unavailable to
an indemnified party with respect to any loss, liability, claim, damage or expense referred to herein, the indemnifying
party, in lieu of indemnifying such indemnified party hereunder, shall contribute to the amount paid or payable by such
indemnified party as a result of such loss, liability, claim, damage or expense (i) in such proportion as is appropriate to
reflect the proportionate relative fault of the indemnifying party on the one hand and the indemnified party on the other
(determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or
omission relates to information supplied by the indemnifying party or the indemnified party and the parties’ relative
intent, knowledge, access to information and opportunity to correct or prevent such untrue statement or omission), or (ii) if
the allocation provided by clause (i) above is not permitted by applicable law or provides a lesser sum to the indemnified
party than the amount hereinafter calculated, then in such proportion as is appropriate to reflect not only the proportionate
relative fault of the indemnifying party and the indemnified party, but also the relative benefits received by the
indemnifying party on the one hand and the indemnified party on the other, as well as any other relevant equitable
considerations. Notwithstanding any other provision of this Section 8(e), no Holder shall be required to contribute any
amount in excess of the amount by which the net proceeds received by such Holder from the sale of the Registrable Securities
pursuant to the Registration Statement exceeds the amount of damages that such Holder has otherwise been required to pay by
reason of such untrue or alleged untrue statement of a material fact or omission, except in the case of fraud or
willful misconduct. No indemnified party guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the
Securities Act) shall be entitled to contribution from any indemnifying party who was not guilty of such fraudulent
misrepresentation.

 

    14

     

    

 

(f) The
indemnity and contribution agreements contained in this Section 8 are in addition to any liability that the indemnifying parties
may have to the indemnified parties and are not in diminution or limitation of the indemnification provisions under the Subscription
Agreement.

 

9. Rule
144. Following the Effective Date, the Company will use its commercially reasonable efforts to timely file all reports required
to be filed by the Company after the date hereof under the Exchange Act and the rules and regulations adopted by the Commission
thereunder, and if the Company is not required to file reports pursuant to such sections, it will prepare and furnish to the Purchasers
and make publicly available in accordance with Rule 144(c) such information as is required for the Purchasers to sell shares of
Common Stock under Rule 144.

 

10. Independent
Nature of Each Purchaser’s Obligations and Rights. The obligations of each Purchaser and each Broker under this Agreement
are several and not joint with the obligations of any other Purchaser or Broker, and each Purchaser and each Broker shall not
be responsible in any way for the performance of the obligations of any other Purchaser or any Broker under this Agreement. Nothing
contained herein and no action taken by any Purchaser or Broker pursuant hereto, shall be deemed to constitute such Purchasers
and/or Brokers as a partnership, an association, a joint venture, or any other kind of entity, or create a presumption that the
Purchasers and/or Brokers are in any way acting in concert or as a group with respect to such obligations or the transactions
contemplated by this Agreement. Each Purchaser and each Broker shall be entitled to independently protect and enforce its rights,
including without limitation the rights arising out of this Agreement, and it shall not be necessary for any other Purchaser or
Broker to be joined as an additional party in any proceeding for such purpose.

 

11.
Miscellaneous.

 

(a) Governing
Law. The parties hereby agree that any dispute which may arise between them arising out of or in connection with this
Agreement shall be adjudicated only before a federal court located in the State of New York, Borough of Manhattan and they
hereby submit to the exclusive jurisdiction of the federal and state courts of the State of New York, Borough of Manhattan
with respect to any action or legal proceeding commenced by any party, and irrevocably waive any objection they now or
hereafter may have respecting the venue of any such action or proceeding brought in such a court or respecting the fact that
such court is an inconvenient forum, relating to or arising out of this Agreement or any acts or omissions relating to the
registration of the securities hereunder, and consent to the service of process in any such action or legal proceeding by
means of registered or certified mail, return receipt requested, in care of the address set forth below or such other address
as the undersigned shall furnish in writing to the other.

 

    15

     

    

 

(b) Remedies.
Except as otherwise specifically set forth herein with respect to a Registration Event, in the event of a breach by the Company
or by a Holder of any of their respective obligations under this Agreement, each Holder or the Company, as the case may be, in
addition to being entitled to exercise all rights granted by law and under this Agreement, including recovery of damages, shall
be entitled to specific performance of its rights under this Agreement. Except as otherwise specifically set forth herein with
respect to a Registration Event, the Company and each Holder agree that monetary damages would not provide adequate compensation
for any losses incurred by reason of a breach by it of any of the provisions of this Agreement and hereby further agrees that,
in the event of any action for specific performance in respect of such breach, it shall not assert or shall waive the defense
that a remedy at law would be adequate.

 

(c) No
Piggyback on Registrations; Prohibition on Filing Other Registration Statements. Except in accordance with the terms of the
registration rights granted to the investors in our 2018 private placement, neither the Company nor any of its security holders
(other than the Holders in such capacity pursuant hereto) may include securities of the Company in any Registration Statements
other than the Registrable Securities. Except pursuant to the terms of the registration rights granted to the investors in our
2018 private placement, the Company shall not file any other registration statements, other than on Forms S-4 or S-8 or their
then equivalents, until all Registrable Securities are registered pursuant to a Registration Statement that is declared effective
by the Commission, provided that this Section shall not prohibit the Company from filing amendments to registration statements
filed prior to the date of this Agreement.

 

(d) Piggy-Back
Registrations. If, at any time during the Effectiveness Period, there is not an effective Registration Statement covering
all of the Registrable Securities and the Company shall determine to prepare and file with the Commission a registration statement
relating to an offering for its own account or the account of others under the Securities Act of any of its equity securities,
other than on Form S-4 or Form S-8 (each as promulgated under the Securities Act) or their then equivalents relating to equity
securities to be issued solely in connection with any acquisition of any entity or business or equity securities issuable in connection
with the Company’s stock option or other employee benefit plans, then the Company shall deliver to each Holder a written
notice of such determination and, if within fifteen days after the date of the delivery of such notice, any such Holder shall
so request in writing, the Company shall include in such registration statement all or any part of such Registrable Securities
such Holder requests to be registered; provided, however, that the Company shall not be required to register any
Registrable Securities pursuant to this Section 11(d) that are eligible for resale pursuant to Rule 144 (without volume restrictions
or current public information requirements) promulgated by the Commission pursuant to the Securities Act or that are the subject
of a then effective Registration Statement that is available for resales or other dispositions by such Holder or otherwise cease
to be deemed “Registrable Securities.”

 

    16

     

    

 

(e) Subsequent
Registration Rights. Until the Registration Statement required hereunder is declared effective by the Commission, the Company
shall not enter into any agreement granting any registration rights with respect to any of its securities to any Person without
the written consent of Holders representing no less than a majority of the outstanding Registrable Securities.

 

(f) Successors
and Assigns. Except as otherwise provided herein, the provisions hereof shall inure to the benefit of, and be binding upon,
the successors, Permitted Assignees, executors and administrators of the parties hereto.

 

(g) No
Inconsistent Agreements. The Company has not entered, as of the date hereof, and shall not enter, on or after the date of
this Agreement, into any agreement with respect to its securities that would have the effect of impairing the rights granted to
the Holders in this Agreement or otherwise conflicts with the provisions hereof.

 

(h) Entire
Agreement. This Agreement and the documents, instruments and other agreements specifically referred to herein or delivered
pursuant hereto constitute the full and entire understanding and agreement between the parties with regard to the subjects hereof.

 

(i) Notices,
etc. All notices, consents, waivers, and other communications which are required or permitted under this Agreement shall be
in writing will be deemed given to a party (a) upon receipt, when personally delivered; (b) one (1) Business Day after deposit
with an nationally recognized overnight courier service with next day delivery specified, costs prepaid) on the date of delivery,
if delivered to the appropriate address by hand or by nationally recognized overnight courier service (costs prepaid); (c) the
date of transmission if sent by facsimile or e-mail with confirmation of transmission by the transmitting equipment if such notice
or communication is delivered prior to 5:00 P.M., New York City time, on a Trading Day, or the next Trading Day after the date
of transmission, if such notice or communication is delivered on a day that is not a Trading Day or later than 5:00 P.M., New
York City time, on any Trading Day, provided confirmation of facsimile is mechanically or electronically generated and kept on
file by the sending party and confirmation of email is kept on file, whether electronically or otherwise, by the sending party
and the sending party does not receive an automatically generated message from the recipients email server that such e-mail could
not be delivered to such recipient; (d) the date received or rejected by the addressee, if sent by certified mail, return receipt
requested, postage prepaid; or (e) seven days after the placement of the notice into the mails (first class postage prepaid),
to the party at the address, facsimile number, or e-mail address furnished by the such party,

 

If
to the Company, to:

 

Amesite
Inc.

205
East Washington Street

Suite
B

Ann
Arbor, Michigan 48104

Attn:
Ann Marie Sastry, CEO

Facsimile:
N/A

Email:
ams@amesite.com

 

    17

     

    

 

with
copy to:

 

Sheppard,
Mullin, Richter & Hampton LLP

30
Rockefeller Plaza

New
York, New York 10112

Attn:
Richard A. Friedman, Esq.

Facsimile:
212.653.8701

Email:
rafriedman@sheppardmullin.com

 

and

 

Ogawa
Professional Corporation

313
Bryant Court

Palo
Alto, California 94301

Attn:
Richard Ogawa, Esq.

 

if
to a Holder, to:

 

such
Holder at the address set forth on the signature page hereto or the Company’s records;

 

or
at such other address as any party shall have furnished to the other parties in writing in accordance with this Section 11(f).

 

(j) Delays
or Omissions. No delay or omission to exercise any right, power or remedy accruing to any Holder, upon any breach or default
of the Company under this Agreement, shall impair any such right, power or remedy of such Holder nor shall it be construed to
be a waiver of any such breach or default, or an acquiescence therein, or of any similar breach or default thereunder occurring;
nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter
occurring. Any waiver, permit, consent or approval of any kind or character on the part of any Holder of any breach or default
under this Agreement, or any waiver on the part of any Holder of any provisions or conditions of this Agreement, must be in writing
and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement, or
by law or otherwise afforded to any holder, shall be cumulative and not alternative.

 

(k) Counterparts.
This Agreement may be executed in any number of counterparts, and with respect to any Purchaser, by execution of an Omnibus Signature
Page to this Agreement and the Subscription Agreement, each of which shall be enforceable against the parties actually executing
such counterparts, and all of which together shall constitute one instrument. In the event that any signature is delivered by
facsimile transmission or by an e-mail, which contains a portable document format (.pdf) file of an executed signature page, such
signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with
the same force and effect as if such facsimile or e-mail of a .pdf signature page were an original thereof.

 

    18

     

    

 

(l) Severability.
In the case any provision of this Agreement shall be invalid, illegal or unenforceable, the validity, legality and enforceability
of the remaining provisions shall not in any way be affected or impaired thereby.

 

(m) Amendments.
Except as otherwise provided herein, the provisions of this Agreement may be amended at any time and from time to time, and particular
provisions of this Agreement may be waived, with and only with an agreement or consent in writing signed by the Company and the
Majority Holders; provided that this Agreement may not be amended and the observance of any term hereof may not be waived with
respect to any Holder without the written consent of such Holder unless such amendment or waiver applies to all Holders in the
same fashion. The Purchasers and Brokers acknowledge that by the operation of this Section, the Majority Holders may have the
right and power to diminish or eliminate all rights of the Purchasers and/or Brokers under this Agreement.

 

(n) Independent
Nature of Holders’ Obligations and Rights. The obligations of each Holder hereunder are several and not joint with the
obligations of any other Holder hereunder, and no Holder shall be responsible in any way for the performance of the obligations
of any other Holder hereunder. Nothing contained herein or in any other agreement or document delivered at any closing, and no
action taken by any Holder pursuant hereto or thereto, shall be deemed to constitute the Holders as a partnership, an association,
a joint venture or any other kind of group or entity, or create a presumption that the Holders are in any way acting in concert
or as a group or entity with respect to such obligations or the transactions contemplated by this Agreement or any other matters,
and the Company acknowledges that the Holders are not acting in concert or as a group, and the Company shall not assert any such
claim, with respect to such obligations or transactions. Each Holder shall be entitled to protect and enforce its rights, including
without limitation the rights arising out of this Agreement, and it shall not be necessary for any other Holder to be joined as
an additional party in any proceeding for such purpose. The use of a single agreement with respect to the obligations of the Company
contained was solely in the control of the Company, not the action or decision of any Holder, and was done solely for the convenience
of the Company and not because it was required or requested to do so by any Holder. It is expressly understood and agreed that
each provision contained in this Agreement is between the Company and a Holder, solely, and not between the Company and the Holders
collectively and not between and among Holders.

 

[COMPANY
SIGNATURE PAGE FOLLOWS]

 

    19

     

    

 

This
Registration Rights Agreement is hereby executed as of the date first above written.

 

	 	The
    Company:
	 	 
	 	AMESITE INC.
	 	 
	 	By:	                   
	 	Name:	 
	 	Title:	 

 

	Purchasers	 	 
	 	 	 
	See Omnibus Signature Pages to Subscription Agreement (Purchasers do not sign here)	 	 
	 	 	 
	Broker (individual):	 	Broker
    (entity):
	 	 	 
	 	 	 
	Print Name	 	Print Name of Entity
	 	 	 
	 	 	By:	             
	Signature	 	Name:	 
	 	 	Title:	 
	 	 	 
	All Holders: Address	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 

 

     

     

    

 

Schedule
1

 

Brokers

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00313-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00313-of-00352.parquet"}]]